Literature DB >> 27723064

The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept.

Mariusz Mogielnicki, Damian Swieczkowski1, Witold Bachorski, Grzegorz Zuk, Natasza Gilis-Malinowska, Aleksander Zarzeka, Piotr Merks, Marcin Gruchala, Milosz Jaguszewski.   

Abstract

Mesh：

Year:  2016        PMID： 27723064     DOI： 10.5603/CJ.2016.0074

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  2 in total

1.  Patient counselling service with the use of pictograms as the example of pharmacist intervention to improving compliance and medicine safety.

Authors:  Piotr Merks; Damian Świeczkowski; Marcin Balcerzak; Urszula Religioni; Ewelina Drelich; Jerzy Krysiński; Dagmara Hering; Miłosz Jaguszewski
Journal:  Cardiol J       Date:  2021-02-26       Impact factor: 2.737

Review 2.  The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.

Authors:  Damian Świeczkowski; Szymon Zdanowski; Piotr Merks; Łukasz Szarpak; Régis Vaillancourt; Milosz J Jaguszewski
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.